Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Segment Income — Specialty Diagnostics by Quarter
Segment Income — Specialty Diagnostics ($M)
Thermo Fisher Scientific Segment Income — Specialty Diagnostics: $341M in Q3 2026, up 6.2% from a year earlier.
Where the Q3 2026 figure comes from
“SD: Segment income 304 306 321 324 1,256 313 334 341”
Source: Q3 2026 Reconciliation of Financial Information ↗
Full breakdown of external/intersegment revenues, Cost of Revenues, SG&A, R&D, Operating Assets (AR + Inventory), CapEx, and Depreciation under the new ASU 2023-07 accounting standard.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up segment Income — Specialty Diagnostics
- Segment Income Margin — Specialty Diagnostics31.0% · Q3 2026
- Margin Expansion (percentage points) — Specialty Diagnostics3.6% · Q3 2026
- Doanh thu khách hàng bên ngoài (External Customer Revenues — Note 11) — Specialty Diagnostics1,188 · Q2 2026
- Intersegment Revenues — Note 11 — Specialty Diagnostics17 · Q2 2026
- Segment Cost of Revenues — ASU 2023-07 — Specialty Diagnostics699 · Q2 2026
- Segment SG&A — ASU 2023-07 — Specialty Diagnostics177 · Q2 2026
- Segment R&D Expense — ASU 2023-07 — Specialty Diagnostics45 · Q2 2026
- Segment Assets: AR + Inventory — Specialty Diagnostics1,323 · Q2 2026
- Segment Purchases of PP&E — Specialty Diagnostics24 · Q2 2026
- Segment Depreciation — Specialty Diagnostics20 · Q2 2026
- Goodwill — Specialty Diagnostics–
Cite this data
StockData. (2026). Thermo Fisher Scientific Segment Income — Specialty Diagnostics ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg-income-sd
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.